(2026). Expression of Concern: TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Expression of Concern: TMEM41A Overexpression Correlates with Poor Prognosis and Immune Alterations in Patients with Endometrial Carcinoma."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Expression of Concern: TMEM41A Overexpression Correlates with Poor Prognosis and Immune Alterations in Patients with Endometrial Carcinoma."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.